HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
15,770
+180 (1.15%)
At close: Dec 5, 2025
-26.31% (1Y)
| Market Cap | 221.45B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 468.52 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 75,837 |
| Average Volume | 151,976 |
| Open | 15,600 |
| Previous Close | 15,590 |
| Day's Range | 15,450 - 15,920 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.49 |
| RSI | 51.43 |
| Earnings Date | Nov 13, 2025 |